Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors

by Sunee Sirivichayakul, Kiat Ruxrungtham, Chaiwat Ungsedhapand, Wichai Techasathit, Sasiwimol Ubolyam, Theshinee Chuenyam, Sean Emery, David Cooper, Joep Lange, Praphan Phanuphak
Published 2018

Young men who have sex with men at high risk for hiv, bangkok msm cohort study, thailand 2006–2014

by Warunee Thienkrua, Frits van Griensven, Philip A. Mock, Eileen F. Dunne, Boonyos Raengsakulrach, Wipas Wimonsate, Nopporn Howteerakul, Chaiwat Ungsedhapand, Anupong Chiwarakorn, Timothy H. Holtz
Published 2019

A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients

by Chaiwat Ungsedhapand, Eugene D.M.B. Kroon, Surapol Suwanagool, Kiat Ruxrungtham, Nongluk Yimsuan, Areerat Sonjai, Sasiwimol Ubolyam, Supranee Buranapraditkun, Surapee Tiengrim, Nadine Pakker, Chaiyos Kunanusont, Joep M.A. Lange, David A. Cooper, Praphan Phanuphak
Published 2018

Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection

by Chaiwat Ungsedhapand, Preeyaporn Srasuebkul, Peter Cardiello, Kiat Ruxrungtham, Winai Ratanasuwan, Eugene D M B Kroon, Metta Tongtalung, Nittaya Juengprasert, Sasiwimol Ubolyam, Umaporn Siangphoe, Sean Emery, Joep M A Lange, David A. Cooper, Praphan Phanuphak
Published 2018